News

  • Calmark recruits new CEO

    As of today, Torbjörn Andersson is new CEO of Calmark Sweden AB. Torbjörn has over 25 years of experience of general management, product development and sales in the life science industry. Torbjörn holds a BSc in Biochemistry, and a MBA with honors from IMD business school in Lausanne, Switzerland. Mathias Karlsson will continue his work in Calmark as Medical Director.

    God jul & Gott nytt år

    Önskar vi på Calmark. Istället för julkort så donerar vi till Lilla barnets fond.

    CEO Mathias giving lunch seminar at Karolinska Institutet

    Calmark CEO Mathias will share his experience on the journey from the clinic and the lab to a venture capital funded medtech company.

    Nov 6th, 12-13, no pre-registration needed, but seats are limited.

    Lennart Nilssonsalen, Nobels väg 15a, Karolinska Institutet, Campus Solna

    New Calmark employee

    We are growing and as of this week Annika Österdahl is part if the Calmark team. Annika will focus on marketing and sales of Calmark’s current and future products.

    Calmark goes to San Fransisco

    Mathias Karlsson, founder and CEO, will represent Calmark at the Founders Club JPM Demo Day at Wilson Sonsini Goodrich & Rosati (WSGR), San Francisco, USA.

    Season greetings

    The year of 2012 has been exciting and eventful for Calmark. We have managed to CE mark our first product hilda NeoTM, started developing and CE marking a smartphone app and we’ve had several patents granted and participated in numerous studies.

    We want to thank everybody we’ve worked with during 2012 and lock forward to new exciting projects and collaborations in 2013. Instead of thanking everybody with Christmas presents we’ve chosen to contribute to Lilla barnets fond.

    Since we’ve outgrown our offices in Albanova we would also like to announce that we are moving to new facilities in Greenhouse labs at the Royal Institute of Technology in Stockholm.

    Merry Christmas and a Happy New Year!

     

    New scientific publication

    A new scientific paper on Lactate dehydrogenase in neonatal intensive care patients has been published in Acta Paediatrica. Read the article on PubMed (PMID: 22963670).

    SvD Näringsliv: Hjalmar Winblad on investment in Calmark

    Svenska Dagbladet, one of Swedens largest daily newspapers, publishes article based on interview with Hjalmar Winbladh on the opportunities when medical technology are combined with new innovations within IT and smartphones. Read the article here (in Swedish)

    Nomination – best mobile health app in Sweden

    Calmark has been nominated to ”Guldmobilen 2012” in the health category. “Guldmobilen”, Swedih for “the Golden Mobile Phone” is a prize that is awarded to the year’s leading innovators and best mobile business in Sweden. Read more about the nomination (in Swedish)

    Calmark investor Hjalmar Winbladh appointed “The Perfect Entrepreneur”

    We’d like to congratulate Hjalmar Winbladh, co-owner Calmark, on his recent award as “The Perfect Entrepreneur”. He was given the prize at a ceremony in Stockholm. Hjalmar will work together with researchers and entrepreneurs at Karolinska Institutet and coach them on their development of mission critical apps that help patients access physicians from remote locations. During the ceremony, Hjalmar also talked about Calmark’s opportunities in the IVD app area.

    Hjalmar is the founder of Pedal and Sendit, which was sold to Microsoft. More recently he has founded Rebtel and Wrapp.

    Read more about Hjalmar and the award at SEB’s web.